Loretto Hospital is among sites that will test new COVID-19 vaccine candidates early next year, with the goal of ensuring minorities are represented in clinical trials.
The West Side safety-net hospital, which treats large numbers of Black and Brown patients, aims to improve racial and ethnic diversity among study subjects. In addition to being disproportionately affected by the pandemic, people of color historically have been underrepresented in clinical trials.
“Too often in our past, we’ve seen vaccines or drug regimens come to market that didn’t work as expected on minority populations, because they weren’t appropriately tested on these groups,” Dr. Lois Clarke, Loretto’s director of clinical research, said in a statement. “If we, as a community, want to benefit from a COVID-19 vaccine, it’s time to step up and make sure we’re being representatively included in the trials.”